全文获取类型
收费全文 | 211895篇 |
免费 | 14712篇 |
国内免费 | 4821篇 |
专业分类
耳鼻咽喉 | 1633篇 |
儿科学 | 3015篇 |
妇产科学 | 3674篇 |
基础医学 | 25240篇 |
口腔科学 | 3670篇 |
临床医学 | 15292篇 |
内科学 | 25654篇 |
皮肤病学 | 2466篇 |
神经病学 | 12242篇 |
特种医学 | 7352篇 |
外国民族医学 | 293篇 |
外科学 | 22498篇 |
综合类 | 31400篇 |
一般理论 | 9篇 |
预防医学 | 16935篇 |
眼科学 | 2661篇 |
药学 | 29066篇 |
93篇 | |
中国医学 | 14517篇 |
肿瘤学 | 13718篇 |
出版年
2023年 | 2408篇 |
2022年 | 3525篇 |
2021年 | 6975篇 |
2020年 | 6748篇 |
2019年 | 6339篇 |
2018年 | 6346篇 |
2017年 | 7108篇 |
2016年 | 7079篇 |
2015年 | 6600篇 |
2014年 | 12188篇 |
2013年 | 14958篇 |
2012年 | 12164篇 |
2011年 | 13822篇 |
2010年 | 10997篇 |
2009年 | 10829篇 |
2008年 | 10503篇 |
2007年 | 10602篇 |
2006年 | 9876篇 |
2005年 | 9165篇 |
2004年 | 7821篇 |
2003年 | 6955篇 |
2002年 | 5424篇 |
2001年 | 4932篇 |
2000年 | 4132篇 |
1999年 | 3463篇 |
1998年 | 2623篇 |
1997年 | 2708篇 |
1996年 | 2477篇 |
1995年 | 2310篇 |
1994年 | 2261篇 |
1993年 | 1868篇 |
1992年 | 1663篇 |
1991年 | 1574篇 |
1990年 | 1382篇 |
1989年 | 1099篇 |
1988年 | 1086篇 |
1987年 | 969篇 |
1986年 | 888篇 |
1985年 | 1259篇 |
1984年 | 1018篇 |
1983年 | 767篇 |
1982年 | 810篇 |
1981年 | 641篇 |
1980年 | 602篇 |
1979年 | 506篇 |
1978年 | 322篇 |
1977年 | 279篇 |
1976年 | 253篇 |
1975年 | 204篇 |
1974年 | 156篇 |
排序方式: 共有10000条查询结果,搜索用时 156 毫秒
1.
2.
3.
4.
5.
《Radiography》2022,28(2):353-359
Patient contact shielding has been in use for many years in radiology departments in order to reduce the effects and risks of ionising radiation on certain organs. New technologies in projection imaging and CT scanning such as digital receptors and automatic exposure control (AEC) systems have reduced doses and improved image consistency. These changes and a greater understanding of both the benefits and the risks from the use of shielding have led to a review of shielding use in radiology. A number of professional bodies have already issued guidance in this regard. This paper represents the current consensus view of the main bodies involved in radiation safety and imaging in Europe: European Federation of Organisations for Medical Physics, European Federation of Radiographer Societies, European Society of Radiology, European Society of Paediatric Radiology, EuroSafe Imaging, European Radiation Dosimetry Group (EURADOS), and European Academy of DentoMaxilloFacial Radiology (EADMFR). It is based on the expert recommendations of the Gonad and Patient Shielding (GAPS) Group formed with the purpose of developing consensus in this area. The recommendations are intended to be clear and easy to use. They are intended as guidance, and they are developed using a multidisciplinary team approach. It is recognised that regulations, custom and practice vary widely on the use of patient shielding in Europe and it is hoped that these recommendations will inform a change management program that will benefit patients and staff. 相似文献
6.
《European journal of surgical oncology》2022,48(3):482-491
ObjectiveTo systematically evaluate the clinicopathological and prognostic value of extra-hepatic bile duct resection (EHBDR) in the surgical management of patients with gallbladder carcinoma (GBC), especially in non-jaundiced patients.MethodsPubMed, EMBASE and the Cochrane Library were searched up to March 1st 2021 for comparative studies between bile duct resected and non-resected groups. RevMan5.3 and Stata 13.0 software were used for the statistical analyses.ResultsEHBDR did not correlate with a better overall survival (OS) (P = 0.17) or disease-free survival (P = 0.27). No survival benefit was also observed in patients with T2N1 (P = 0.4), T3N0 (P = 0.14) disease and node-positive patients (P = 0.75), rather, EHBDR was even harmful for patients with T2N0 (P = 0.01) and node-negative disease (P = 0.02). Significantly higher incidences of recurrent disease (P = 0.0007), postoperative complications (P < 0.00001) and positive margins (P = 0.02) were detected in the bile duct-resected group. The duration of postoperative hospital stay between the two groups was comparable (P = 0.58). Selection bias was also detected in our analysis that a significantly higher proportion of advanced lesions with T3-4 or III-IV disease was observed in the bile duct-resected group (P < 0.00001). EHBDR only contributed to a greater lymph yield (P = 0.01).ConclusionEHBDR has no survival advantage for patients with GBC, especially for those with non-jaundiced disease. Considering the unfairness of comparing OS between jaundiced patients receiving EHBDR with non-jaundiced patients without EHBDR, we could only conclude that routine EHBDR in non-jaundiced patients is not recommended and future well-designed studies with more specific subgroup analyses are required for further validation. 相似文献
7.
8.
目的 测定儿童1型糖尿病(T1DM)患者骨密度(BMD),分析探讨骨密度变化的影响因素。方法 选取于2018年1月—2021年6月于我院收治的儿童1型糖尿病患者76例,收集性别、年龄、发病年龄、身高、体重、BMI、病程等基本资料,检测空腹血糖、空腹C肽、糖化血红蛋白(HbA1c)、血碳酸氢根(HCO3-)、血清碱性磷酸酶(ALP),应用双能X线吸收测定法测定骨密度,获取Z值。结果 76例儿童1型糖尿病患者骨密度Z值为-0.93±2.14。HbA1c、病程与骨密度Z值呈负相关,差异具有统计学意义(分别B=-0.334,P<0.001;B=-0.191,P=0.017)。结论 儿童1型糖尿病患者骨密度低于健康儿童,血糖控制不良、病程长是1型糖尿病儿童骨密度减低的危险因素。 相似文献
9.
10.
Major depressive disorder and other neuropsychiatric disorders are often managed with long-term use of antidepressant medication. Fluoxetine, an SSRI antidepressant, is widely used as a first-line treatment for neuropsychiatric disorders. However, fluoxetine has also been shown to increase the risk of metabolic diseases such as non-alcoholic fatty liver disease. Fluoxetine has been shown to increase hepatic lipid accumulation in vivo and in vitro. In addition, fluoxetine has been shown to alter the production of prostaglandins which have also been implicated in the development of non-alcoholic fatty liver disease. The goal of this study was to assess the effect of fluoxetine exposure on the prostaglandin biosynthetic pathway and lipid accumulation in a hepatic cell line (H4-II-E-C3 cells). Fluoxetine treatment increased mRNA expression of prostaglandin biosynthetic enzymes (Ptgs1, Ptgs2, and Ptgds), PPAR gamma (Pparg), and PPAR gamma downstream targets involved in fatty acid uptake (Cd36, Fatp2, and Fatp5) as well as production of 15-deoxy-Δ12,14PGJ2 a PPAR gamma ligand. The effects of fluoxetine to induce lipid accumulation were attenuated with a PTGS1 specific inhibitor (SC-560), whereas inhibition of PTGS2 had no effect. Moreover, SC-560 attenuated 15-deoxy-Δ12,14PGJ2 production and expression of PPAR gamma downstream target genes. Taken together these results suggest that fluoxetine-induced lipid abnormalities appear to be mediated via PTGS1 and its downstream product 15d-PGJ2 and suggest a novel therapeutic target to prevent some of the adverse effects of fluoxetine treatment. 相似文献